Literature DB >> 9356460

Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera.

U Kruse1, J S Iacovoni, M E Goller, P K Vogt.   

Abstract

The v-jun oncogene encodes a nuclear DNA binding protein that functions as a transcription factor and is part of the activator protein 1 complex. Oncogenic transformation by v-jun is thought to be mediated by the aberrant expression of specific target genes. To identify such Jun-regulated genes and to explore the mechanisms by which Jun affects their expression, we have fused the full-length v-Jun and an amino-terminally truncated form of v-Jun to the hormone-binding domain of the human estrogen receptor. The two chimeric proteins function as ligand-inducible transactivators. Expression of the fusion proteins in chicken embryo fibroblasts causes estrogen-dependent transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356460      PMCID: PMC24963          DOI: 10.1073/pnas.94.23.12396

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences.

Authors:  T J Bos; F S Monteclaro; F Mitsunobu; A R Ball; C H Chang; T Nishimura; P K Vogt
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

2.  A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor.

Authors:  D Picard; S J Salser; K R Yamamoto
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

3.  The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.

Authors:  N J Webster; S Green; J R Jin; P Chambon
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

4.  Isolation of hormone-producing clonal lines of human choriocarcinoma.

Authors:  P O Kohler; W E Bridson
Journal:  J Clin Endocrinol Metab       Date:  1971-05       Impact factor: 5.958

5.  Avian sarcoma virus 17 carries the jun oncogene.

Authors:  Y Maki; T J Bos; C Davis; M Starbuck; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors.

Authors:  S H Hughes; J J Greenhouse; C J Petropoulos; P Sutrave
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

Review 7.  AP-1 function and regulation.

Authors:  M Karin; Z g Liu; E Zandi
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

8.  The human estrogen receptor has two independent nonacidic transcriptional activation functions.

Authors:  L Tora; J White; C Brou; D Tasset; N Webster; E Scheer; P Chambon
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

9.  Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.

Authors:  M Eilers; D Picard; K R Yamamoto; J M Bishop
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

10.  The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.

Authors:  L Tora; A Mullick; D Metzger; M Ponglikitmongkol; I Park; P Chambon
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  3 in total

1.  Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation.

Authors:  S l Fu; I Bottoli; M Goller; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

2.  v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.

Authors:  W Clark; E J Black; A MacLaren; U Kruse; N LaThangue; P K Vogt; D A Gillespie
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.

Authors:  M Aoki; A Hecht; U Kruse; R Kemler; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.